Health Canada drug identification number

DIN 02485966 — LORBRENA 25 MG

LORBRENA is a tablet of Lorlatinib marketed by PFIZER CANADA ULC. The full Lorlatinib monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02485966
Brand name
LORBRENA
Active ingredient
Lorlatinib
Strength
25 MG
Dosage form
TABLET
Route
ORAL
Manufacturer
PFIZER CANADA ULC
Health Canada status
MARKETED
Drug class
Tyrosine kinase inhibitor (ALK/ROS1 inhibitor)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Lorlatinib products

DINBrandStrengthFormManufacturerStatus
02485974 LORBRENA 100 MG TABLET PFIZER CANADA ULC MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.